The store will not work correctly when cookies are disabled.
Di sodium,3,5-Bis-phosphonooxy-benzoate
ID: ALA314675
PubChem CID: 44321575
Max Phase: Preclinical
Molecular Formula: C7H6Na2O10P2
Molecular Weight: 314.08
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1cc(OP(=O)([O-])O)cc(OP(=O)([O-])O)c1.[Na+].[Na+]
Standard InChI: InChI=1S/C7H8O10P2.2Na/c8-7(9)4-1-5(16-18(10,11)12)3-6(2-4)17-19(13,14)15;;/h1-3H,(H,8,9)(H2,10,11,12)(H2,13,14,15);;/q;2*+1/p-2
Standard InChI Key: KEIFPVBGKXHYJP-UHFFFAOYSA-L
Molfile:
RDKit 2D
21 19 0 0 0 0 0 0 0 0999 V2000
4.4875 -2.5542 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
3.9750 -0.9667 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
0.3792 0.2625 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
2.5417 1.5208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5417 2.3458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 0.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8292 0.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1042 -0.1417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9792 -0.1417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9750 -1.7917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3458 0.6708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8292 1.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 1.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5417 -0.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8000 -0.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0250 -0.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.8250 2.7583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7917 0.9875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1500 -0.9667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2542 2.7583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5708 0.7500 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
3 8 1 0
4 13 2 0
5 4 1 0
6 9 1 0
7 14 1 0
8 7 1 0
9 2 1 0
10 2 1 0
11 3 1 0
12 7 2 0
13 6 1 0
14 6 2 0
15 2 2 0
16 3 2 0
17 5 2 0
18 3 1 0
19 2 1 0
20 5 1 0
4 12 1 0
M CHG 4 1 1 10 -1 11 -1 21 1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.08 | Molecular Weight (Monoisotopic): 313.9593 | AlogP: 0.33 | #Rotatable Bonds: 5 |
Polar Surface Area: 170.82 | Molecular Species: ACID | HBA: 5 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.47 | CX Basic pKa: ┄ | CX LogP: -0.28 | CX LogD: -9.85 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.48 | Np Likeness Score: 0.42 |
References
1. Miller MJ, Braccolino DS, Clearly DG, Ream JE, Walker MC, Sikorski JA. (1994) EPSP synthase inhibitor design IV. New aromatic substrate analogs and symmetrical inhibitors containing novel 3-phosphate mimics., 4 (21): [10.1016/S0960-894X(01)80293-6] |